Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azd7986
2. Ins-1007
3. Ins1007
4. N-(1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo(d)oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide
1. Azd7986
2. 1802148-05-5
3. Ins1007
4. (s)-n-((s)-1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide
5. Brensocatib [usan]
6. Azd 7986
7. Azd-7986
8. Ins-1007
9. 25cg88l0bb
10. Chembl3900409
11. (2s)-n-[(1s)-1-cyano-2-[4-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide
12. (s)-n-((s)-1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide
13. 1,4-oxazepine-2-carboxamide, N-((1s)-1-cyano-2-(4-(2,3-dihydro-3-methyl-2-oxo-5-benzoxazolyl)phenyl)ethyl)hexahydro-, (2s)-
14. Ins 1007
15. Brensocatib [inn]
16. Unii-25cg88l0bb
17. Brensocatib [who-dd]
18. Gtpl9412
19. Schembl16932317
20. Ex-a1866
21. Bdbm50195235
22. Pz1130
23. Who 11097
24. Ac-36222
25. As-84225
26. Bb177302
27. Hy-101056
28. Cs-0020766
29. J3.556.230c
30. A17095
31. D84088
32. A937370
33. (2s)-n-{(1s)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
34. (s)-3-[4-(2-oxo-3-methyl-2,3-dihydrobenzoxazole-5-yl)phenyl]-2-[(hexahydro-1,4-oxazepine-2alpha-yl)carbonylamino]propanenitrile
| Molecular Weight | 420.5 g/mol |
|---|---|
| Molecular Formula | C23H24N4O4 |
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 420.17975526 g/mol |
| Monoisotopic Mass | 420.17975526 g/mol |
| Topological Polar Surface Area | 104 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 699 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of non-cystic fibrosis bronchiectasis
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Brensocatib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brensocatib, including repackagers and relabelers. The FDA regulates Brensocatib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brensocatib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Brensocatib supplier is an individual or a company that provides Brensocatib active pharmaceutical ingredient (API) or Brensocatib finished formulations upon request. The Brensocatib suppliers may include Brensocatib API manufacturers, exporters, distributors and traders.
Brensocatib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Brensocatib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Brensocatib GMP manufacturer or Brensocatib GMP API supplier for your needs.
A Brensocatib CoA (Certificate of Analysis) is a formal document that attests to Brensocatib's compliance with Brensocatib specifications and serves as a tool for batch-level quality control.
Brensocatib CoA mostly includes findings from lab analyses of a specific batch. For each Brensocatib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Brensocatib may be tested according to a variety of international standards, such as European Pharmacopoeia (Brensocatib EP), Brensocatib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brensocatib USP).
LOOKING FOR A SUPPLIER?
